Lisa Walter
Stock Analyst at RBC Capital
(2.64)
# 2,156
Out of 4,959 analysts
3
Total ratings
100%
Success rate
14.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lisa Walter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Maintains: Outperform | $45 → $41 | $19.19 | +113.65% | 1 | Aug 7, 2025 | |
| APLS Apellis Pharmaceuticals | Maintains: Sector Perform | $17 → $19 | $27.97 | -32.07% | 1 | Aug 1, 2025 | |
| EYPT EyePoint Pharmaceuticals | Initiates: Outperform | $28 | $11.79 | +137.49% | 1 | Jun 17, 2025 |
Viridian Therapeutics
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $41
Current: $19.19
Upside: +113.65%
Apellis Pharmaceuticals
Aug 1, 2025
Maintains: Sector Perform
Price Target: $17 → $19
Current: $27.97
Upside: -32.07%
EyePoint Pharmaceuticals
Jun 17, 2025
Initiates: Outperform
Price Target: $28
Current: $11.79
Upside: +137.49%